Article attacks risk reduction and incidence of LE
I've heard this Sarah McLaughlin speak at the NLN: and notably she showed a picture of a patient who had written on her arm "No IV, no blood draws" and was disgusted. She consistently under-reports the incidence of LE. So, now she gets published in a major surgical journal, saying "Don't worry, and don't do risk reduction--they're myths". ARGHH.
Good data shows the risk much higher.
The women were measured, and LE was defined as a 10% volume increase. But, from the study
More ALND than SLNB patients perceived arm swellingat 6 and 12 months. Interview data identified a similar number of ALND patients perceiving swelling at both6 and 12 months (25% vs 31%, p ¼ 0.80) (Table 2). The perception of swelling in SLNB patients was also similar at 6 and 12 months (11% vs 6%, p ¼ 0.76), but was consistently less than that seen in patients having ALND. Interestingly, at all time points and regardless of the type of axillary surgery, more patients perceivedswelling than had measured lymphedema.
Do you think that's because they HAVE LE??? 10% volume increase is not required to have LE....
Gosh, I was told not to worry, and due to my ignorance, it contributed to my early development of LE, despite my 3% risk...
http://www.facs.org/news/jacs/lymphedema0313.html
Breast Cancer Patients’ Fear of Developing Lymphedema
Far Exceeds Risk
New Journal of the American College of Surgeons study reveals trends in patient worry and risk-reducing behaviors in women undergoing breast cancer treatment
Chicago (February 25, 2013): Women who have had the lymph nodes under their arm surgically removed during breast cancer treatment are warned to avoid certain practices that can cause lymphedema—a condition that causes chronic, painless swelling in the arm. Now, a new study published in the March issue of the Journal of the American College of Surgeons suggests that the vast majority of women who undergo breast cancer operations worry about developing this complication and that this fear far exceeds their actual risk of getting lymphedema. In fact, most women adopt four to five commonly recommended measures to prevent this incurable condition despite little data supporting the efficacy of these precautionary behaviors.
During breast cancer treatment, women are advised to take certain preventive steps to reduce their chance of developing lymphedema. These preventive measures include vigilant skin care to avoid injury (avoidance of needle punctures or blood draws), not getting one’s blood pressure taken in the affected arm, frequent use of compression garments, and various other practices. The truth is that clinicians don’t really know if any of these precautionary measures change the outcomes for these women.
“Clinicians don’t really know what causes lymphedema, and there is an overall lack of data supporting or refuting these risk-reducing practices,” said lead study author Sarah McLaughlin, MD, FACS, assistant professor of surgery at the Mayo Clinic in Jacksonville, FL. “And because women worry about that disfiguring process, they adopt practices that are basically grounded in myth, not fact.”
About 90 percent of women who will develop lymphedema do so within three years of breast cancer treatment. It occurs in about 20 percent of women who undergo axillary lymph node dissection (ALND)—a procedure in which 10–20 lymph nodes (on average) in the armpit are removed and checked for cancer cells. It also develops in about 5 percent of women who undergo sentinel lymph node biopsy (SLNB)—a less extensive procedure in which only a few lymph nodes closest to the breast are taken out and analyzed.
To document the lymphedema rate, patient worry, and risk-reduction behaviors in women undergoing breast cancer surgery, researchers at the Mayo Clinic in Florida followed 120 women, ages 52-68, for 12 months. Of those women, 53 underwent ALND and 67 had SLNB. The same two clinicians saw all patients postoperatively at one-, six-, and 12-month intervals. During these visits, the women completed questionnaires about their lymphedema risk-reduction behaviors, and assessments of their fear and worry about developing the condition.
Researchers found that 75 percent of women who had ALND, and 52 percent of women who had SLNB, worried about getting lymphedema. While lymph node removal can increase the chance of developing this complication, the study results showed that only 19 percent of those who had ALND actually developed lymphedema, and only 3 percent of those who underwent SLNB got it. The study also showed that at 12 months, the extent of axillary surgery (the number of nodes taken out in the armpit) was the only significant risk for developing lymphedema. Age, weight, type of breast operation (breast-conserving or mastectomy), or radiation were not linked to an increase in lymphedema.
What’s more, researchers found that the majority of women adopted as many as five precautionary behaviors as early as six months after breast cancer operations and maintained these behaviors long term despite their actual risk—meaning they undertook these measures regardless of whether they had undergone ALND or SLNB and their course of treatment (radiation and adjuvant chemotherapy).
The investigators say that future research should be aimed at better predicting which women will develop lymphedema, thus allowing for targeted prevention and intervention strategies and individualized plans for risk-reducing behaviors for each woman during and after her breast cancer treatment.
“This is the first step to quantify the problem. The aim is to educate not just patients but providers about what we really need to do, which is to better stratify patients in terms of what their true risk really is,” Dr. McLaughlin said. “The goal is to be able to tell the average woman, ‘Listen, your risk is low so you don’t need to do these other things, and you can go about your life and be active and not worry to such a great extent that you are going to suffer this complication.’ The goal is to alleviate much of the anxiety that women carry,” Dr. McLaughlin said.
Other study participants include Sanjay Bagaria, MD; Tammeza Gibson, PA-C; Michelle Arnold, BS; Nancy Diehl, BS; Julia Crook, PhD; Alexander Parker, PhD; and Justin Hung Nguyen, MD, FACS, all from Mayo Clinic in Florida.
Funding for this research was provided by a Bankhead Coley Florida Cancer Research Program
Comments
-
So... the goal is to reduce the anxiety about developing LE. The hell with reducing the risk of LE.
Yeah, that's a good idea.
Leah
-
I was told (at a major Chicago breast center) 'don't worry, honey...your risk with SNB is so minimal that you don't need to worry about it.' Yeah, right. Here I am.
Kira, do you have a resource for a study -- somewhere -- that demonstrated that we can have up to 30% excess lymph in a limb without measurable swelling? I've read that, but I don't know where it comes from.
These researchers didn't find a high incidence of measurable LE. But they report that their study subjects took as many as five precautionary measures not to get it. Ummm....isn't it possible that had no precautions been taken, the incidence of 'measured' LE would have been higher?
Carol
-
Carol, let me look. I know Binney cites that, and I do have the Foldi textbook.
This study makes me want to weep/scream.....
-
AAARRRRRGGGGGHHHHHHHHHHHHHHHHHHHHH!!!!!!!!!!!!!
-
Just read Foldi, and latency stage is pathologically associated with changes in the adipose tissue, even without overt swelling. Also, there are very depressing discussions of how the lymphatic system fatigues with both lymph node removal--which damages the remaining nodes and radiation.
In latency, there was an autoposy study of two women who had ALND and no swelling for long periods of time, yet on autopsy they had pathologic alterations.
They state: Stage 0 latency: focal fibrosclerotic tissue alterations
"When lymphedema first develops, it is an initial reversible stage in which swelling is caused by protein rich subfascial edema. Subfascial edema cannot be detected clinically, but measurements show that lymph congestion extends into the subfascial space: subfascial pressure is increased." p 231
"In awareness of this fact that the latency stage can progress to chronic lymphedema at any time, lymphologists should explain to patients ....The advice to avoid injuries in the tributary region of the axillary lymph nodes is based on the fact that injuries not only destroy lymph vessels, but also lead to acute inflammation, which increases the lymphatic protein and water loads" p 231
-
And they determined that radiation didn't increase risk (???)
From Foldi Text:
-
I'm insulted, totally insulted. In other works, "Don't Worry, Be Happy". (Btw, I never did like that song.)
-
My email back to the publication:
"Interesting but dangerous article. You have managed to distill a complicated and controversial medical subjectinto a few paragraphs and one person's opinion. The figures cited are not necessarily reproducible because the definition of "lymphedema," while well-defined here, is not well-defined in the medical community.
While I understand that the precautionary measures mentioned are not evidence-based, I am seriously concerned that Dr. McLaughlin's goal seems to be preventing anxiety, not preventing a debilitating condition. I also suspect that the measures mentioned are far more annoying to medical providers than they are burdensome to patients. I remain strongly unconvinced."I'm sure it's going to go to some flunky. That doesn't appear to be any sort of peer-reviewed journal, it looks likeone of what we call a "throw-away." But I'm not a surgeon so I don't know for sure how seriously anybody takes it. If it were a real journal, could write a real letter. Wish I had the time to track it down a little.
-
Outfield, thank you--beautifully said! Perhaps someone of worth will see it; you never know.
-
Well, I kicked it up to the researcher who patented the survey they used and her take was that it's a seriously flawed study: not blinded, single center, and their statement about the risk is so low: don't worry--she compared it to the risk for breast cancer, which is around 1 in 9 and yet we screen all women if possible.
She is reviewing the article and will address it.
She also didn't feel it met the criteria to be in this journal, which unfortunately, is a reputable journal
She said: From weight of evidence viewpoint, it is a single-site, nonblinded, surveillance study, with 120 enrolled. Not a randomized clinical trial, and too short follow-up. Not sufficient to change practice.
I really hope that she can shut this woman down, as the study is seriously flawed. And Sarah McLaughlin has published before debunking the incidence of LE and the need for risk reduction. And now she created an a study to "prove her point" and deny our reality.
Here is the author's email: McLaughlin.Sarah@mayo.edu
-
Agree with points made above. My first impression was: small numbers, no control group, only 1 year (when they reference 90% of cases developing up to 3 years out - are they continuing to follow?) and, most importantly, written by a SURGEON probably in denial about the damage she causes! LE is mentioned as an incurable condition but also as "painless" which is simply not true.
Medical literature, along with social science & psychology as well as other fields, is riddled with studies that do not make any attempt to neutralize investigation bias. In other words, conclusions are formed before the work begins and the data is manipulated to fit. Often, the researcher is unaware of their own underlying assumptions. That is why peer review and replication are so critical. If others cannot reproduce the results, the whole thing is called into question.
I thought Mayo people would adhere to higher standards...
-
vinrph: so well put. Ever read the New Yorker article about the failure of replication and scientific bias, "The Truth Wears Off"?:
http://www.newyorker.com/reporting/2010/12/13/101213fa_fact_lehrer
I emailed Andrea Cheville, who I admire tremendously, to let her know this came from Mayo, and I assume she knows this surgeon as they were at the same NLN conference.
I've circulated the article to all the major lymphedema organizations, who apparently don't have google alerts and this was news to them, but they're universally upset and hopefully will address this.
I have the full article. Anyone who wants to read it, just pm me.
-
Here is the email I sent this evening. It's long, because I had a lot to say.
Dear Dr. McLaughlin:
While reading your article, Trends in Risk Reduction Practices for the Prevention of Lymphedema in the First 12 Months after Breast Cancer Surgery, a few points in the study description and discussion caught my attention. I have breast cancer-related lymphedema; my treatment consisted of bilateral mastectomy and sentinel node biopsy. I was not given any pre-surgical lymphedema measures, risk counseling, or risk-reduction education. I find many of your article’s points and conclusions to be disturbing, and in this letter I shall attempt to explain why.
You make the point that studies disagree on which risk factors are significant and they present contradictory data concerning the influence of each risk factor on the future development of lymphedema. This is precisely why the pendulum of doubt must swing to the side of risk-reduction behaviors. When in doubt, err to the side of caution.
Your study goes on to say that because risk factors are inconsistent, clinicians educate all breast cancer survivors on precautionary behaviors in an effort to reduce patient risk for lymphedema. If only that were true! Lymphedema risk counseling and related education on precautionary measures is inconsistent at best. Please do not confuse the lymphedema education / breast-cancer intake process at the Mayo Clinic with process at large. Speaking as a woman with BCRL who networks with many other BCRL patients, it is our experience that outside of major cancer centers, lymphedema often is discussed only if the breast cancer patient specifically asks about her risk.
You explain that the National Lymphedema Network acknowledges the paucity of high quality evidence supporting these practices and admits recommendations are based on expert opinion and physiologic principles. It would be unethical to enroll breast cancer patients and survivors in a study in which they are asked to burn, poke, or cut their arms, or to fly twenty hours weekly, to answer the question of injury’s role in provoking lymphedema in an at-risk arm. Therefore, ‘a paucity of evidence’ is the body of knowledge from which we are obligated to infer lymphedema risk, and that is precisely why we seek expert opinion to interpret physiologic principles and suggest common-sense precautionary behaviors. How is it helpful to dismiss the role of expert opinion?
You have hypothesized that…despite the lack of evidence supporting precautionary behaviors to avoid lymphedema development, the majority of women fear lymphedema and, therefore, will follow risk reduction practices. Dr. McLaughlin, the most honest statement in your article is that women fear lymphedema. Indeed we do. What enables a woman to engage in medicine’s draconian assaults against cancer? It is her confidence in research and in the science of breast cancer treatment. Breast cancer research has been funded with mega dollars over many decades, but of course, the same cannot be said about lymphedema research. Which should I fear most: arguably the most studied disease that might afflict the human body, or a lesser-known condition whose cause, let alone cure, is not well understood? We fear lymphedema precisely because of the lack of evidence to support solid risk assessment and risk-avoidance strategies. No one really knows the extent to which the standard risk-reduction behaviors reduce our risk of lymphedema or its sequelae, because random controlled-trial risk-reduction studies would in fact be unethical research. We are obligated to make our risk-reduction decisions in the murky environment of uncertainty; is uncertainty an argument against taking precautions? I think not, especially considering the stakes: Lymphedema is forever, and once we have it, there are no do-overs, no second chances to take the discarded precautions. We do fear lymphedema so yes…we will follow risk reduction practices.
I leave to lymphedema clinicians, educators and researchers the task of questioning some of your study design choices, such as using a ten percent diagnostic criterion for lymphedema (which is a very high bar and may well explain why, interestingly, at all time points and regardless of the type of axillary surgery, more patients perceived swelling than had measured lymphedema. I find it stunning that your study finds that at 12 months, we found extent of axillary surgery to be the only significant risk for developing lymphedema. BMI at the time of surgery, and radiation, are well documented risks for lymphedema. That your study did not identify these risks raises a very serious question of study design, including the apparent dismissal of latent, or stage 0 lymphedema as worthy of risk correlation.
Finally, your study participants practiced risk reducing behaviors throughout the study. Is it possible that your very low documented lymphedema incidence is in fact, the product of the risk reduction decisions made not out of fear, but in considered response to the lymphedema education provided at the time of breast cancer intake?
Dr. McLaughlin, you seem to be advocating for an end to the general application of precautionary behaviors to all breast cancer patients, on the grounds that there exists persisting patient and clinician confusion. In my view, the only persisting confusion is why any clinician would deny a woman information and the choice of whether to adopt risk-reduction strategies, based on a misguided goal of reducing fear through the application of ignorance.
Sincerely,
-
Carol... EXCELLENT LETTER!!!
-
I can't tell if that study made me more angry or depressed. I doubt that my letter will have any impact, but I have great, great hopes that the various LE organizations Kira sent the study to will indeed respond and be taken seriously. My arm hurts today. I was given zero heads-up or education on LE risk and precautions. Would those have made a difference? Maybe, but I'll never know, of course. It's so incredibly sad to think that I missed my chance at a 'maybe' and that there are so-called researchers who think that's appropriate. Usually I can keep a glass-half-full outlook even about LE, but to think that someone who has a platform is actually arguing in favor of keeping us in the dark? It's beyond my ability to comprehend.
-
Carol, did you send this letter to the journal as well? Use your credentials as an NLN Lymph Science Advocate. Excellent letter, compelling, and it needs to be published.
Brava!
Binney -
I just hope all the LE organizations can put their nonsense aside and actually be effective advocates in this case.
When I was put on the board of one of the national organizations, there was concern that I was an advocate, and I was specifically warned against being an advocate.....Really???
-
Binney, for whatever it's worth, I just emailed the Journal editors with the text of my letter to Dr. McLaughlin. I wish other patients would send a note to those editors as well. It's really fair to respond to an article only if you have read it in full, but I hope some of our bco members will take the time to do so. The email address for the journal editors is jacsedit@facs.org .
-
I also think as "lay people" you can respond to her media releases as well. As you can't read the entire article without a subscription.
-
Grrr!
This is just SO infuriating, kira !
I have bene talking to my BS over the last few days ( REQ. a breast MRI rather than mammo) and I have posted on a few threads ( incl. the gRRRR!)
I am stunned at certain findings that were never discolsed to me, but FAR more stunned at her attitude. I have been made to feel like a real PITA.Articles like these do not help!
I have called all over my City , all the hospitals etc ... trying to start a LE support group and they keep telling me, but we already have a BC support group ( grrr!)
OR, possibly worse, they name that ' local dr. ' in our area who is supposed to be oin the forefront of LE , who is in it for profit. He is really making a name for himself.This is very upsetting indeed!
-
Carol
Thanks so much for a detailed, well written and articulate letter!
Right now, all I can say is grrrr! -
Kira, that is too much for my brain to read, but I get the jist of what she is saying from the synopses on here and the complaints.
What a disgusting piece of crap (and yes I know I have a potty mouth on here when I find something really upsetting).
That is all we need is someone putting us back in the stone ages for LE.
I am so glad that those of you that have enough information to send her your facts and refute her bullcrap can do it.
I can't cuz I can't cite studies and don't know enough to do it, and frankly, with my cognitive impairments, I can't do it.
GO GET HER LADIES!!!
After all the crap I went through with my LE with my appendectomy, I will be writing on my arm should I ever have surgery again, and if I can't Brian will. I don't care who the heck I offend. Keep your needles and blood pressure of my damn arms!!!
-
Dr. McLaughlin sent me a very kind and respectful response to my email. In her note, she said that my comments " are meaningful especially from the perspective of an affected survivor. I will review them and take them into account in my future works." Dr. McLaughlin sent me some studies to review, and she ended by asking me to "please remember that part of the problem in diagnosing lymphedema is the lack of standardized definitions and assessment criteria for evaluation." I certainly agree with that last point!
I'm pretty sure that she remains unconvinced that risk-reduction practices are justifiable based on evidence from research, but I remain hopeful that she might consider our need for information -- and we should be reminded that the evidence is, in fact, often weak--so we can make our own decision regarding whether to follow the traditional risk-reduction advice or not.
The Journal acknowledged my email, and in fact I received a very nice note from the managing editor. My letter is to be forwarded on to the editor-in-chief, but as I'm not a clinician, I doubt very much that the Journal will publish my rebuttal to Dr. McLaughlin's study. Which is a shame, because although I disagree with her interpretations, Dr. McLaughlin makes some valid points about research limitations, and we should be having a lymphedema-community-wide discussion of what the weak evidence for risk-reduction behavior means for us in real life. A rebuttal letter or editorial in the Journal might prompt that kind of discussion.
As for me, I will continue to avoid BPs and needle sticks in my LE arm; I won't be hopping into a sauna; and I'll be slathering sunscreen and insect repellent with the best of them this summer. I already have LE, so my risk-reduction behavior is aimed at keeping it in its current mild state and avoiding infection. If I didn't have LE, I would be doing exactly the same thing. But that's just my personal, non-clinical take on 'the evidence.'
-
Carol
Where did you write ?
I wrote to the jacs email:
RE: Breast Cancer Patients’ Fear of Developing Lymphedema Far Exceeds Risk
As a breast cancer patient, I found this article to be very disturbing.
In the above-mentioned article, Dr. MacLaughlin stated : “… these visits, the women completed questionnaires about their lymphedema risk-reduction behaviors, and assessments of their fear and worry about developing the condition.”
What does fear and worry have to do with developing LE? Are the researchers suggesting it is a contributing factor? At best, the mention of fear and worry muddies the waters in this solemn issue and is confusing. At worst, it is offensive to those of us who have developed LE. I was too ignorant to worry because nobody bothered to inform me there was any risk whatsoever. Now that I do have this “painless swelling of the arm”, I find myself worrying frequently, but not because I have mental issues - because I have a physical condition that warrants serious concern.
This condition is chronic, life altering and can progress. It has the potential to disable. Small nuisances like a mosquito bite can wreak havoc with the thick protein rich substance that runs through my compromised lymphatic system. The slightest cut can cause cellulitis, which may be life threatening.The good Dr. said: “The goal is to alleviate much of the anxiety that women carry,” {Dr. McLaughlin said.} I would hope for a much more lofty goal. Dr. MacLaughlin stated: “Clinicians don’t really know what causes lymphedema, and there is an overall lack of data supporting or refuting these risk-reducing practices,” That would be an honorable goal – to explore what causes lymphedema.
The article implied that following innocuous risk reducing behaviors immobilizes women. I am more active now than I was before my LE. Avoiding a blood pressure cuff on my arm does not stop me from working full time and doing aerobics, taking care of my granddaughter and going grocery shopping or taking on new projects. I am very concerned that articles such as yours can actually encourage both doctors and patients to ignore modest risk reducing behaviors that could permanently change a person’s life.
With a simple lumpectomy and SNB with two nodes out and absolutely no radiation, my fear is not of developing LE because I already have it, but of causing the development in the next woman whose profile is like mine. Yes, there is a proven cause and effect correlation between breast cancer treatment and lymphedema. I know. I went in to the operating room without it, and I came out forever changed.
First, do no harm.
-
Purple, that's a great email you sent! You made some wonderful points. I sent my email to the journal, as well, so I think the same editor will see yours. If you receive no response, it could be that she's overwhelmed with letters--wouldn't that be great?
-
I'm sure it has been discussed, but this is so gendered. I don't think such risks in men's health are met with dismissiveness in this way. Women really do still get treated like silly girls who worry too much.
-
That reminds me of my mother who proposed that if I did not wear my sleeve, I would not have a LE problem, because then I wouldn't be reminded of it ... It is all in your head, you see. Meanwhile, she has LE herself due to surgery for ovarian cancer (LE in the leg).
-
Purple, nice job! LtotheK, that's a worthwhile perspective to send along to the editor as well (though I have to say that men who develop LE after prostate surgery get the shrug worse than we do
). Still, the premise of this particular article is directed at women and the message is basically "keep calm and carry on."
And I say, GOOD FOR ALL THOSE WOMEN IN THE STUDY WHO WERE PRACTICING RISK REDUCTION!!!As far as I can see, their efforts were paying off.
The more voices the better here, so please, all, even a short note to the editors will help make them aware of the concern patients have about this. Hey! It's almost Lymphedema Awareness Day (March 6)--let's make this our LE Awareness project!
Here's the journal's contact information:
jacsedit@facs.org
Anne Wolfe
Managing EditorDo it! And THANKS!
Binney -
I will write - thank you! I just had a MAJOR FLARE up of Lymphedema
because I lifted 3 grocery bags....
-
Thanks
I should add that I also received a reply from Dr MacLaughlin.
I was not particularly thrilled with it. Essentially, she told me that she could not alter what her pts said, but merely report it.I told her that I understood that and was in perfect agreement with it... I was only suggesting that these pts be ENCOURAGED by their DRS to practice risk reduction. I felt the article was discouraging.
She also said that she had no way of predicting who would or would not get LE. I pointed out that this was precisely the reason I thought it important to have these pts. actively taking risk precaution.
sigh.
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team